Search results
Diabetic ketoacidosis (DKA) is a frequent and potentially life-threatening complication of type 1 diabetes. Though preventable and despite advances in monitoring technologies, insulin therapeutics and insulin delivery systems, the rates of both community and hospital acquired DKA remain largely unchanged. Although mortality today is relatively
DIABETIC KETOACIDOSIS – INITIAL MANAGEMENT GUIDE. DIAGNOSIS OF DKA BLOOD GLUCOSE(BG) > 11*- (glucose may be normal in a known diabetic) + ACIDOSIS - pH <7.3 or HCO3-<15mmol/l + KETONAEMIA – Bld Ketones> 3mmol/l.
22 maj 2020 · This is a subcutaneous (SubQ) insulin protocol that replaces insulin drip needs for mild to moderate DKA. Procedures are adapted for COVID-related considerations of minimizing risk to staff while optimizing patient safety and health.
Intravenous Insulin Prescription and Fluid Protocol. FOR HYPEROSMOLAR HYPERGLYCAEMIC STATE (HHS) BOX 5: INTRAVENOUS FLUID PRESCRIPTION. For information on dilutions, infusion rates, compatibilities and monitoring parameters, consult the: Injectable Medicines Guide or contact Medicines Information.
Add Dextrose (D51⁄2NS or D5NS*) to IVF @ 150 – 250 mL/h to maintain serum glucose 150 – 200 mg/dL and continue insulin at same rate. Titrate insulin to a minimum 0.1 Units/kg/hr and glucose goal between 150 – 200 mg/dL until ketosis and anion gap resolves.
Diabetic Ketoacidosis (DKA) Two Bag System Protocol [3361] DKA: Blood glucose greater than 250 mg/dL, arterial or venous pH less than 7.3, serum bicarbonate less than 15 mEq/L anion gap greater than 12 and ketonuria or ketonemia. Discontinue all previous insulin orders and oral diabetes medications.
Document in special instructions section of the IV insulin order form that the patient is on DKA protocol. Use any soluble insulin eg: Actrapid, Humulin R. Concentration should be 50 units of insulin in 49.5mL 0.9% sodium chloride through a syringe driver. Step 4 - Continuation of intravenous insulin Long acting (basal) subcutaneous insulin can be
